Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
November 26, 2024 at 14:39 PM EST
Trump's FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink approved for new studies, company says.
